We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms
The European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE) consortium brings together international experts of different disciplines in an efficient and decisive collaborative network, to coordinate the response and control of an emerging new disease.
The European Clinical Research Infrastructures Network (ECRIN) is focused on synergizing and connecting the clinical research capabilities within the European continent.
The Colon Therapy Research (COLTHERES) consortium brings together clinical centers and translational researchers funded in the European Union to define and perform biomarker driven clinical trials to improve cancer therapy outcomes. This 4-year consortium will use comprehensively molecularly-annotated colon cancers as a "test-bed" to define specific biomarkers of response or resistance to signaling pathway agents.
The Consortium for Functional Glycomics (CFG) serves to combine the expertise and glycomics resources to reveal functions of glycans and glycan-binding proteins (GBPs) that impact human health and disease. The CFG offers resources to the community free of charge, including glycan array screening services, a reagent bank, and access to a large glycomics database and data analysis tools.
The Global CEO Initiative on Alzheimer's Disease is a public- private partnership that aims to stop Alzheimer's disease and dementia. The consortium brings together international public authorities with the private sector to serve as the leading business voice on Alzheimer's disease.
The Centre for Drug Safety Science (CDSS) aims to coordinate the fundamental clinical and basic research into the causes, characteristics and consequences of adverse drug reactions (ADRs). It was established as a joint venture between the Universities of Liverpool and Manchester to bring together a critical mass of knowledge and technologies in order to advance our understanding of Adverse Drug Reactions.
The Clinical Decision Support (CDS) Consortium aims to enable the use of electronic health records (EHRs) to improve the safety and quality of medical care by pairing these data resources with clinical decision support systems to effectively influence physician behavior. CDS aims to advance a variety of techniques designed to facilitate and guide doctors'' decision making toward evidence‐based practice.
The Centre for Drug Research and Development (CDRD) is a Canadian consortium that serves as an integrated national drug development and commercialization center. CDRD''s mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector.
The Centre for Commercialization of Regenerative Medicine''s (CCRM) is an industry consortium that aims to accelerate the application of regenerative medicine to clinical practice. Stakeholder in the consortium include the pharmaceutical, devices, reagents, tools, biomaterials and cell therapeutic companies.
The Consortia Advancing Standards in Research Administration Information (CASRAI) is dedicated to reducing the administrative burden on researchers and improving business intelligence capacity of research institutions and funders.The Consortia Advancing Standards in Research Administration Information (CASRAI) aim is to improve the flow of information within and between research stakeholders by developing and maintaining a common and extensible dictionary of terms and exchangeable business objects to advance collaboration. The members include research-performing and research-funding organizations, as well as the service providers that support them. CASRAI goal is to create a central and standardized method for research teams to quickly produce any documents needed by funders and institutions. CASRAI aims to have the following outcomes: save time for researchers in applying & reporting to their funding agencies; Improve access to quality data for institutions and funders; Simplify the measurement of research impacts on society; Provide peer networking opportunities for teams tackling administrative data issues
The Collaboratory of AIDS Researchers for Eradication (CARE) is a consortium of scientific experts in the field of HIV latency from several U.S. and European academic research institutions as well as Merck Research Laboratories working together to find a cure for HIV.
The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) aims to advance the safe and reliable production of biopharmaceuticals by mitigating the risk of cell culture contamination through agents such as viruses or mycoplasma, by creating a central database of accumulated industry knowledge. Currently, industrial knowledge about contaminating adventitious agents and successful approaches to combat these specific agents is largely limited to each company''s individual experience. The collection, analysis and dissemination of the full body of industry experience would enhance the reliable manufacture and supply of such safe and effective medications. This consortium operates under the umbrella of MIT Center for Biomedical Innovation (CBI).
The Cell4Cure consortium aims to advance the cGMP production of therapeutic cell therapies. The consortium is led by Cellectis, a biotech focused in the development of adoptive immunotherapies and CELLforCURE, the largest commercial industrial facility for the production of therapeutic cell therapies in Europe. The consortium also includes seven public-sector organizations and university medical centers, who collaborate with the private sector companies.
The BioMedical Materials (BMM) consortium focuses on advancing the use of new materials to biomedical research. As a public-private partnership, the consortium includes the participation of over 50 leading institutions, corporations, and health foundations, with support from the government of the Netherlands. The activities of this consortium have ended. The website and materials will be available until 12-31-2015.
This is the synthetic antigen sequence from which Biotrend anti-SST2A antibodies are raised.
Software package for editing and preparation of bitmap and vector graphics
Software for image capture, processing and analysis with Leica fluorescence and confocal microscopes.
User interface software for Carl Zeiss light microscopy imaging systems. ZEN is the universal user interface you will see on every imaging system from ZEISS. After selecting fluorophore, ZEN applies the necessary settings to collect and organize data.
The Care Connectivity Consortium (CCC) is working to address and overcome the most critical and key challenges to effective health information exchange (HIE), to make HIE technologies more versatile and valuable for patients, caregivers, and health care organizations. By developing improved technologies for comprehensive, secure, reliable and innovative HIE, the CCC aims to enable health care provider organizations nationwide to deliver better, timelier, and more informed patient care.
The Cancer Genomics of the Kidney (CAGEKID) consortium brings together expertise in clinical care and epidemiology with genomic expertise. This consortium is an effort of the larger International Cancer Genome Consortium (ICGC), which has the goal of obtaining a comprehensive description of genomic, transcriptomic and epigenomic changes in 50 different tumour types and/or subtypes with the aim of elucidating the genomic changes present in the many forms of cancers that contribute to the burden of disease throughout the world.